AndroGel

ASCEND Therapeutics U.S., LLC🇺🇸 United States

FDA Page

Effective Date: Dec 20, 2023
Approval ID: f4e8d29b-8707-4d47-e053-2a95a90aecee
Products: 1 registered
Version: 127

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

AndroGel ® (testosterone gel) 1.62% for topical use CIII These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%. A ndroGel (testosterone gel) 1.62% for topical use CIII Initial U.S. Approval: 1953

Quick Stats

Total Products1

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.